July 1999 - Dalton Chemical Laboratories, a longtime leader in commercial oligo supply in Canada, has expanded its biopolymer operation with the launch of a custom peptide synthesis operation. The same commitment of quality and service that has made Dalton Canada's Core FacilityTM is now available for a broad range of custom peptide synthesis related services. The peptides will be analyzed by MS to confirm identity and a combination of CE and HPLC to confirm purity.
The launch will occur during the 2nd week of July, and is designed to give Canadian researchers a commercial source within Canada to supply to their biopolymer needs. Founded in 1986, Dalton has a broad range of chemistry expertise that is well utilized in the synthesis of bioactive molecules.
For peptides, special synthesis or analytical projects, Dalton offers a range of capabilities and technologies to assist drug development and research.
About Dalton
Dalton Chemical Laboratories Inc. is a manufacturer of fine chemicals, pharmaceuticals, custom peptides, and a supplier of chemistry and analytical services to the biotechnology and pharmaceutical industry. As a full service manufacturer of Active Pharmaceutical Ingredients, Dalton produces APIs on a gram, kilogram, and multi-kilogram scale in its state-of-the-art cGMP facilities. Working with customers to generate new drugs and optimize the synthesis and production of their potential therapeutic candidates, Dalton offers full service capabilities in drug development and manufacturing, including sterile filling of finished products.
For further information contact:
|
